Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION [501257] (NDC 0173-0898-03) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 20, 2026 , from http://ppman.hank.ai/transparency/procedure/0173-0898-03/by-state?code_type=NDC
“DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION [501257] (NDC 0173-0898-03) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/0173-0898-03/by-state?code_type=NDC. Accessed
November 20, 2026 .
“DOSTARLIMAB-GXLY 50 MG/ML INTRAVENOUS SOLUTION [501257] (NDC 0173-0898-03) by State,” HANK Price Transparency ,
accessed November 20, 2026 ,
http://ppman.hank.ai/transparency/procedure/0173-0898-03/by-state?code_type=NDC.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
NDC · across United States
0173-0898-03 — Dostarlimab-gxly 50 Mg/ml Intravenous Solution [501257]
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$22,219
National median
$22,219 – $22,219
IQR (p25 – p75)
1
hospitals filing
1
states
Walking in without insurance?
Cash / self-pay price
Cash median
$453
vs. negotiated
-98.0%
Hospitals reporting
29
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 0173-0898-03 (NDC), with interquartile range
State Median p25 p75
MD $22,219 $22,219 $22,219